Answers are grounded in this paper and cite their sources.
The 2024 CPG for RA, which provide recommendations that reflect the current healthcare environment for rheumatoid arthritis in Japan, can be used effectively as a tool for shared decision-making between rheumatologists and patients in the treatment of RA.
No takes yet. Share an insight, caveat, or question.
Harigai et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: